# Effect of Ivabradine in Stage D HF/Cardiogenic Shock Patients on Dobutamine

> **NCT03387605** · PHASE4 · UNKNOWN · sponsor: **Loyola University** · enrollment: 40 (estimated)

## Conditions studied

- Heart Failure
- Cardiogenic Shock
- Tachycardia

## Interventions

- **DRUG:** Ivabradine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03387605
- **Lead sponsor:** Loyola University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-15
- **Primary completion:** 2020-01
- **Final completion:** 2020-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03387605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03387605, "Effect of Ivabradine in Stage D HF/Cardiogenic Shock Patients on Dobutamine". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03387605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*